Authors
Latest:
Jordan Miller, MD: 2024 Dermatology PredictionsAdvancements in assistance from artificial intelligence include ambient listening to take notes during physician and patient conversations.
Latest:
The Dx and Rx of Congenital Malalignment Syndrome in ChildrenCongenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Latest:
Redefining Vitiligo Management: FDA-Approved Topical Ruxolitinib and the Evolving Treatment ParadigmPearl E. Grimes, MD, discusses the evolving treatment paradigm for vitiligo, highlighting the role of FDA-approved topical ruxolitinib and its impact on management strategies.
Latest:
Eczema Prevalence Varies by Race and Ethnicity, With Overall Increase SeenInvestigators compared these outcomes due to limited research in the space, with previous surveys suggesting care disparities.
Latest:
Jill Waibel, MD, FAAD: Innovations in Laser Modalities for the Treatment of ScarsWaibel shared pearls in laser therapy and other scar treatment modalities in her talks at the American Academy of Dermatology Annual Meeting.
Latest:
The Burden of AD Flares and Impact of Ruxolitinib Initiation on Utilization of Other TherapiesPosters at AMCP Nexus analyzed the burden of flares on patients with atopic dermatitis (AD) and the impact initiating ruxolitinib cream had on use of other therapies.
Latest:
85% of Survey Respondents Do Not Know What Actinic Keratosis IsThe survey conducted by Almirall included participants in the US and Europe.
Latest:
Pulsed Dye Lasers for Cosmetic ProceduresPulsed dye lasers are now being used for several different dermatologic conditions.
Latest:
New Tech for SkinThere are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.
Latest:
Rare Immune Cell May Predict Immunotherapy Response in MelanomaVd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.
Latest:
Pediatric Melanoma in Review: Providing Considerations for DermatologistsPediatric melanoma, though rare, is the deadliest skin cancer in children, with 300-500 US cases annually.
Latest:
Addressing Causes of Female Hair Loss and Exploring Preventative MeasuresThis expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.
Latest:
Comparing Devices to Assess Facial Pigmentary and Inflammatory ConditionsPrecision measurements are necessary to improve the current therapeutic armamentarium in pigmentary disorders.
Latest:
Navigating Pregnancy, Dermatology, and Drug SafetyKatherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.
Latest:
Challenges and Successes in Photodynamic TherapyBrad Glick, DO, MPH, discusses common challenges clinicians may encounter with photodynamic therapy (PDT) and offers resolution strategies, while also sharing insights on the skin conditions and patient populations where PDT has proven to be a successful treatment option.
Latest:
Lauren Miller, PA-C, Highlights the Value of Collaboration With APPs and MoreMiller is presenting 3 sessions at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.
Latest:
Case 2: Male, 20 Years OldAn expert in the management of skin conditions provides an overview of a 20-year-old male diagnosed with atopic dermatitis, discussing key insights from a round table discussion. The conversation focused on effective management strategies, best practices for prior authorization approvals, and the significance of treatment vehicles.
Latest:
Expert Perspectives on BOLT clinical trial dataJohn Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
Latest:
The Role of Pharmacists in Skin Care Education in the Age of Social MediaSocial media is fraught with misinformation. Pharmacists play a key role in breaking through the fallacies with facts and education on skin care.
Latest:
Clinical Considerations for Monkeypox in PregnancyWhat we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.
Latest:
Expert Insights Into the Relationship Between the Hippo Pathway and Extensive Fibrosis in HSResearchers from the University of Michigan and Almirall found that the profibrotic fibroblast response in HS can be modulated through inhibition of the Hippo pathway.
Latest:
FDA approves topical for actinic keratosisTirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.
Latest:
5 steps to make telehealth work for physicians and patientsThere are barriers to telehealth adoption that physicians must overcome to realize the technology’s promise.
